Whole-exome sequencing identifies prognostic mutational signatures in gastric cancer

BACKGROUND: Gastric cancer (GC) is a heterogeneous disease, and is a leading cause of cancer deaths in Eastern Asia. Genomic analysis, such as whole-exome sequencing (WES), can help identify key genetic alterations leading to the malignancy and diversity of GC, and may help identify new drug targets...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ann Transl Med
Asıl Yazarlar: Zhu, Zhenxin, Fu, Hongbing, Wang, Shengzhou, Yu, Xinxin, You, Qing, Shi, Mengyao, Dai, Chun, Wang, Guan, Cha, Wei, Wang, Weimin
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: AME Publishing Company 2020
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7729362/
https://ncbi.nlm.nih.gov/pubmed/33313229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm-20-6620
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller